Showing results (31-40 of 185) with videos related to
Sort By:
Pageof 19
The Analyst|January 23, 2003
Development of an LC/MS method for the trace analysis of triacetone triperoxide (TATP)Leo Widmer, Stuart Watson, Konrad Schlatter, et al.Pharmacology & Therapeutics|September 4, 2007
Potential of p38-MAPK inhibitors in the treatment of ischaemic heart diseaseJames E Clark, Negin Sarafraz, Michael S MarberSport Sciences for Health|February 1, 2023
The impact of bias on developing healthy lifestyles, understanding if personal perspectives impact modeling and recommendations of diet and exercise by educators to their studentsJames E Clark, Emily Sirois, Martha F WiszniakOptics Express|November 10, 2016
Encoding complex valued fields using intensityEdoardo De Tommasi, Luigi Lavanga, Stuart Watson, et al.Bjpsych Bulletin|September 20, 2018
An evaluation of sleep disturbance on in-patient psychiatric units in the UKSam Horne, Katherine Hay, Stuart Watson, et al.Psychopharmacology|March 10, 2004
Corticosteroid-serotonin interactions in depression: a review of the human evidenceRichard J Porter, Peter Gallagher, Stuart Watson, et al.Philosophy, Ethics, and Humanities in Medicine : PEHM|February 14, 2022
Clusters, lines and webs-so does my patient have psychosis? reflections on the use of psychiatric conceptual frameworks from a clinical vantage pointTibor Zoltan Kovacs, Reece William Hill, Stuart Watson, et al.Pregnancy Hypertension|February 26, 2021
The association between mental illness, psychotropic medication use and hypertensive disorders in pregnancy: A multicentre studyJacqueline Frayne, Stuart Watson, Martien Snellen, et al.Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|June 3, 2020
The impact of maternal perinatal depression on exposure to reading and screen time for their infants: pilot findings from the MPEWS StudyGrace Cowderoy, Josephine Power, Andrew Lewis, et al.The International Journal of Neuropsychopharmacology|December 1, 2005
Facial expression perception: an objective outcome measure for treatment studies in mood disorders?Helen R Venn, Stuart Watson, Peter Gallagher, et al.Pageof 19